CALL TO CONGRESS: CONQUER DIABETES Trademark Information

Trademark by AMERICAN DIABETES ASSOCIATION, INC.

public policy and lobbying services, namely, promoting the interests of diabetes patients and awareness of diabetes issues by diabetes advocates in Washington DC in the fields of legislation and regulation

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (035)
Advertising; business management; business administration; office functions.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: CALL TO CONGRESS: CONQUER DIABETES
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
6/20/2008
Serial Number: 78813509
Filing Date: 2/13/2006
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: public policy and lobbying services, namely, promoting the interests of diabetes patients and awareness of diabetes issues by diabetes advocates in Washington DC in the fields of legislation and regulation
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 3/27/2007
Last Applicant/Owner:
AMERICAN DIABETES ASSOCIATION, INC.
Alexandria, VA 22311
Mark Drawing Code: Drawing/Design + Words
Design Search:
Plain single line circles (Geometric figures and solids - Coding and searching guide) see more design...
Two concentric circles (Geometric figures and solids - Coding and searching guide) see more design...
Obelisks (Dwellings, Building, Monuments, Stadium, Fountains, Structural works and Building materials - Monuments, stadiums, fountains) see more design...
Register Type: Principal
Disclaimer: ("CONGRESS" and "DIABETES")
Correspondent:
CAESAR, RIVISE, BERNSTEIN, COHEN & POKOT
1635 MARKET STREET SEVEN PENN CENTER
11TH FLOOR
PHILADELPHIA PA 19103-2212
Current Status:
ABANDONED - NO STATEMENT OF USE FILED
6/20/2008
Correspondent Search:
Manny D. Pokotilow is a correspondent of CALL TO CONGRESS: CONQUER DIABETES trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on